What question did this study set out to answer?

The study aims to evaluate microglial pathology in multiple sclerosis using PET imaging.

April 10, 2026Open Access

PET imaging of microglial pathology in multiple sclerosis

Key Points

The study aims to evaluate microglial pathology in multiple sclerosis using PET imaging.
Utilized PET imaging to assess brain inflammation in multiple sclerosis patients.
Compared findings with MRI results to determine detection capabilities of each method.
Evaluated glial responses to emerging neuroprotective therapies.
PET imaging identified inflammation that MRI could not detect.
Highlighted the role of microglial activity in the pathophysiology of MS.
Demonstrated potential for PET to guide therapeutic strategies in MS.

Abstract

Recent advances establish PET as an essential research tool for evaluating the presence of smouldering inflammation in MS brain not detectable using MRI. Furthermore, PET-based methods have proven suitable for measuring glial responses to potentially neuroprotective therapies currently under development.

Read Full Paperexternally

Bookmark

View Full Paper

Cite This Study

Hartiala et al. (Mon,) studied this question.

synapsesocial.com/papers/69d896046c1944d70ce072f2 https://doi.org/https://doi.org/10.1097/wco.0000000000001490

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

Bookmark

View Full Paper